BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19268636)

  • 1. [Cyclic neutropenia: a de novo case and treatment with G-CSF].
    Iglesias Blázquez C; Mata Zubillaga D; Ledesma Benítez I; Martínez Badás JP; Marugán de Miguelsanz JM
    An Pediatr (Barc); 2009 Apr; 70(4):403-5. PubMed ID: 19268636
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia.
    Yetgin S; Ozbek N
    Turk J Pediatr; 1998; 40(3):421-4. PubMed ID: 9763907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
    Kahl C; Leithäuser M; Freund M
    Dtsch Med Wochenschr; 2002 Jul; 127(27):1473-8. PubMed ID: 12098099
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
    Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium septicum myonecrosis in congenital neutropenia.
    Barnes C; Gerstle JT; Freedman MH; Carcao MD
    Pediatrics; 2004 Dec; 114(6):e757-60. PubMed ID: 15574607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
    Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
    Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P; Messer J; Paupe A; Espagne S; Kacet N; Mouchnino G; Klosowski S; Krim G; Lescure S; Le Bouedec S; Meyer P; Astruc D
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
    Dale DC
    J Support Oncol; 2005; 3(2 Suppl 1):39-41. PubMed ID: 15794500
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe chronic neutropenia--a case report.
    Bahl S; Vurgese T; Parappil A
    Indian J Pathol Microbiol; 2004 Oct; 47(4):523-5. PubMed ID: 16295383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient use of G-CSF.
    Wonder M
    Pharmacoeconomics; 1997 Mar; 11(3):287-9. PubMed ID: 10165317
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential for immune reconstitution through G-CSF treatment of HIV patients.
    Von Aulock S; Hartung T
    Arch Immunol Ther Exp (Warsz); 2002; 50(2):111-20. PubMed ID: 12022700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing passively acquired autoimmune neonatal neutropenia: a case study.
    Fung YL; Pitcher LA; Taylor K; Minchinton RM
    Transfus Med; 2005 Apr; 15(2):151-5. PubMed ID: 15859983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated vascular papules in an immunodeficient patient being treated with granulocyte colony-stimulating factor.
    Lenczowski JM; Cassarino DS; Jain A; Turner ML
    J Am Acad Dermatol; 2003 Jul; 49(1):105-8. PubMed ID: 12833018
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is granulocyte colony-stimulating factor therapy a risk factor for myelodysplasia/leukemia in patients with congenital neutropenia?
    Niemeyer CM; Kratz CP
    Haematologica; 2005 Jan; 90(1):2-3. PubMed ID: 15644298
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor induced reduction in pulpal necrosis.
    Yamasaki M; Nakamura K; Amano K; Matsui H; Nakamura H
    Int Endod J; 2008 Jul; 41(7):593-601. PubMed ID: 18479372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label use of granulocyte colony-stimulating factor in noncongenital neutropenia: retrospective data from the Italian Neutropenia Registry.
    Fioredda F; Calvillo M; Renga D; Bonanomi S; Ciliberti A; Martire B; Ghilardi R; Dufour C
    Pediatr Hematol Oncol; 2008 Jun; 25(4):371-4. PubMed ID: 18484485
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression and purification of canine granulocyte colony-stimulating factor (cG-CSF).
    Yamamoto A; Iwata A; Saito T; Watanabe F; Ueda S
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):221-5. PubMed ID: 19339059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.